......SMARTEST Trial......
Phase 2 Completed
30 enrolled
ACTolog
Phase 1 Completed
38 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Phase 1 Completed
20 enrolled 10 charts
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
70 enrolled 10 charts
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
Phase 1/2 Completed
9 enrolled
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Phase 1/2 Completed
70 enrolled 17 charts
EPICAL
Phase 1/2 Completed
23 enrolled
ATLANTIS
Phase 3 Completed
613 enrolled 46 charts
Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Completed
10 enrolled 16 charts
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
Phase 2 Completed
11 enrolled 12 charts
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 3 Completed
216 enrolled
PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer
Phase 1 Completed
12 enrolled 16 charts
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase 1 Completed
60 enrolled 15 charts
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Phase 1/2 Completed
55 enrolled 22 charts
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Phase 2 Completed
12 enrolled
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
Phase 1 Completed
36 enrolled
START
Phase 3 Completed
1,513 enrolled 12 charts
Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)
Phase 2 Completed
171 enrolled 12 charts
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
Phase 1/2 Completed
178 enrolled 11 charts
Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease
Phase 2 Completed
22 enrolled 6 charts
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide
Phase 2 Completed
64 enrolled
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
Phase 1 Completed
8 enrolled
PMR-MM-002
Phase 1 Completed
10 enrolled
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer
Phase 3 Completed
400 enrolled
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
Phase 3 Completed
398 enrolled
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Phase 2 Completed
40 enrolled
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
Phase 2 Completed
24 enrolled 9 charts
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Phase 2 Completed
3 enrolled
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
8 enrolled
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
Phase 2 Completed
90 enrolled
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Phase 1 Completed
20 enrolled
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled
A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
100 enrolled